Results for tag: "Angiogenesis Inhibitor"

Angiogenesis inhibitors are drugs used to treat hematological diseases, such as cancer, by blocking the growth of new blood vessels. These drugs work by targeting the proteins that control the formation of new blood vessels, thus preventing the growth of tumors. They are used in combination with other treatments, such as chemotherapy and radiation therapy, to improve the effectiveness of the treatment. Angiogenesis inhibitors are used to treat a variety of hematological diseases, including leukemia, lymphoma, and multiple myeloma. They are also used to treat solid tumors, such as breast, lung, and colorectal cancer. The angiogenesis inhibitor market is a rapidly growing sector of the pharmaceutical industry. It is expected to continue to grow as new treatments are developed and approved for use. Some companies in the angiogenesis inhibitor market include Genentech, Merck, Pfizer, and Novartis. Show Less Read more